×
About 1,590 results

ALLMedicine™ Pelvic Lymph Node Dissection Center

Research & Reviews  581 results

Lymph node staging with fluorine-18 prostate specific membrane antigen 1007-positron em...
https://doi.org/10.1007/s00259-022-05827-4 10.3322/caac.21660 10.5301/uro.5000139 10.1097/JU.0000000000001698 10.1200/JCO.2020.38.15_suppl.5502 10.1097/JU.0000000000000531 10.1007/s00259-020-04974-w 10.2967/jnumed.119.229187 10.1007/s00259-021-05424-x 10.2967/jnumed.120.258574 10.1007/s00259-017-3740-2 10.1016/j.diii.2020.09.001 10.2967/jnumed.118.222513 10.1159/000497280 10.1016/j.eururo.2016.12.003
European Journal of Nuclear Medicine and Molecular Imaging; Hermsen R, Wedick EBC et. al.

May 12th, 2022 - Fluorine-18 (18F) prostate-specific membrane antigen (PSMA) 1007 (18F-PSMA-1007) is a radiotracer used in prostate cancer (PCa) staging. So far, no large histopathological validation study has been conducted. The objective was to determine diagnos...

Conservative Surgery in Treating Patients With Low-Risk Stage IA2 or IB1 Cervical Cancer
https://clinicaltrials.gov/ct2/show/NCT01048853

May 2nd, 2022 - PRIMARY OBJECTIVE: I. To evaluate the safety and feasibility of performing conservative surgery in women with stage IA2 or IB1 carcinoma of the cervix with favorable pathologic features. SECONDARY OBJECTIVES: I. To estimate the cervix cancer recur...

Radiotherapy plus androgen deprivation therapy for prostate-specific antigen persistenc...
https://doi.org/10.1111/cas.15383
Cancer Science; Shiota M, Takamatsu D et. al.

Apr 30th, 2022 - The treatment for lymph node involvement (LNI) after radical prostatectomy (RP) has not been established. This study aimed to reveal the outcomes of various management strategies among patients with LNI after RP. Retrospectively, 561 patients with...

Laparoscopic Approach to Cervical Cancer
https://clinicaltrials.gov/ct2/show/NCT00614211

Apr 20th, 2022 - Primary Objective: To compare disease-free survival amongst patients who undergo a total laparoscopic (TLRH) or robotic radical hysterectomy (TRRH) verses those who undergo a total abdominal radical hysterectomy (TARH) for early stage cervical can...

see more →

Guidelines  2 results

Japan Society of Gynecologic Oncology guidelines 2013 for the treatment of uterine body...
https://doi.org/10.1007/s10147-016-0981-1
International Journal of Clinical Oncology; Ebina Y, Katabuchi H et. al.

Apr 27th, 2016 - The third version of the Japan Society of Gynecologic Oncology guidelines for the treatment of uterine body neoplasms was published in 2013. The guidelines comprise nine chapters and nine algorithms. Each chapter includes a clinical question, reco...

Robot-assisted radical cystectomy and urinary diversion: technical recommendations from...
https://doi.org/10.1016/j.eururo.2014.12.027
European Urology; Chan KG, Guru K et. al.

Jan 18th, 2015 - The technique of robot-assisted radical cystectomy (RARC) has evolved significantly since its inception >10 yr ago. Several high-volume centers have reported standardized techniques with refinements and subsequent outcomes. To review all existing ...

see more →

Clinicaltrials.gov  33 results

Conservative Surgery in Treating Patients With Low-Risk Stage IA2 or IB1 Cervical Cancer
https://clinicaltrials.gov/ct2/show/NCT01048853

May 2nd, 2022 - PRIMARY OBJECTIVE: I. To evaluate the safety and feasibility of performing conservative surgery in women with stage IA2 or IB1 carcinoma of the cervix with favorable pathologic features. SECONDARY OBJECTIVES: I. To estimate the cervix cancer recur...

Laparoscopic Approach to Cervical Cancer
https://clinicaltrials.gov/ct2/show/NCT00614211

Apr 20th, 2022 - Primary Objective: To compare disease-free survival amongst patients who undergo a total laparoscopic (TLRH) or robotic radical hysterectomy (TRRH) verses those who undergo a total abdominal radical hysterectomy (TARH) for early stage cervical can...

S1011 Standard or Extended Pelvic Lymphadenectomy in Treating Patients Undergoing Surgery for Invasive Bladder Cancer
https://clinicaltrials.gov/ct2/show/NCT01224665

Apr 6th, 2022 - OBJECTIVES: Primary To compare disease-free survival (DFS) of patients with muscle-invasive urothelial carcinoma of the bladder undergoing radical cystectomy with extended pelvic lymph node dissection (PLND) or standard pelvic lymphadenectomy. Sec...

Adenocarcinoma of the Uterine Cervix and HPV
https://clinicaltrials.gov/ct2/show/NCT05267834

Mar 8th, 2022 - The incidence of cervical cancer in developed countries declined considerably in the last few decades. This has been possible for efficient screening programs to which HPV vaccines have been added over the past 15 years. Despite this global reduct...

Lymphoedema and Nocturia/ Nocturnal Polyuria After Pelvic Lymph Node Dissection for Urogenital Cancer
https://clinicaltrials.gov/ct2/show/NCT05266157

Mar 4th, 2022 - After the treatment of urogenital cancer, a person may develop lymphoedema of the leg(s) and/ or midline region. Lymphoedema is the result of a dysfunction in the lymphatic system and is characterized by excessive retention of lymphatic fluid in t...

see more →

News  20 results

Neoadjuvant Atezolizumab/Chemo Shows Encouraging Efficacy in Muscle-Invasive Bladder Cancer
https://www.onclive.com/view/neoadjuvant-atezolizumab-chemo-shows-encouraging-efficacy-in-muscle-invasive-bladder-cancer

Mar 23rd, 2022 - The addition of atezolizumab (Tecentriq) to neoadjuvant gemcitabine and cisplatin (GC) generated a high rate of non–muscle-invasive downstaging following radical cystectomy, which correlated with improved relapse-free survival (RFS) and overall su...

Neoadjuvant Enfortumab Vedotin Demonstrates Encouraging Activity in Cisplatin-Ineligible Muscle-Invasive Bladder Cancer
https://www.onclive.com/view/neoadjuvant-enfortumab-vedotin-demonstrates-encouraging-activity-in-cisplatin-ineligible-muscle-invasive-bladder-cancer

Mar 18th, 2022 - Enfortumab vedotin (Padcev) produced promising antitumor activity when used as neoadjuvant treatment in patients with muscle invasive bladder cancer (MIBC) who were not eligible for cisplatin, according to preliminary findings from cohort H of the...

Walsh's Quest to Understand Male Anatomy Revolutionized the Prostatectomy
https://www.onclive.com/view/walshs-quest-to-understand-male-anatomy-revolutionized-the-prostatectomy

Oct 6th, 2021 - Patrick C. Walsh, MD Until the mid-1970s, the radical prostatectomy ranked among the most dreaded of all surgeries in men. Each procedure entailed a frenzied effort to navigate uncharted anatomy and avoid copious bleeding and, following surgery, ...

Lymph Node Dissection in Prostate Cancer: 'Jury Is Still Out'
https://www.medscape.com/viewarticle/958421

Sep 9th, 2021 - The role of pelvic lymph node dissection (PLND) in patients with localized prostate cancer remains controversial. Although guidelines are increasingly recommending extended PLND alongside radical prostatectomies, the evidence to date has not clear...

Briganti 2019 nomogram predicts lymph node invasion in prostate cancer
https://www.mdedge.com/fedprac/article/242035/hepatocellular-carcinoma/briganti-2019-nomogram-predicts-lymph-node-invasion

Jun 24th, 2021 - Key clinical point: The Briganti 2019 nomogram accurately predicted lymph node invasion in adults with high-risk, clinically localized prostate cancer. Major finding: The area under the curve for the Briganti 2019 was 0.

see more →